UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 28, 2004
MOLECULAR DEVICES CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
0-27316 94-2914362
(Commission File Number) (IRS Employer Identification No.)
1311 Orleans Drive
Sunnyvale, CA 94089
(Address of Principal Executive Offices, including Zip Code)
Registrant's telephone number, including area code: (408) 747-1700
-----------------
- --------------------------------------------------------------------------------
Item 2.02. Results of Operations and Financial Condition.
On October 28, 2004, Molecular Devices Corporation ("Molecular Devices")
reported its financial results for the quarter ended September 30, 2004. A copy
of the press release issued by Molecular Devices on October 28, 2004 concerning
the foregoing results is furnished herewith as Exhibit 99.1 and is incorporated
herein by reference.
The information in this report, including the exhibit hereto, shall not be
deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended, or otherwise subject to the liabilities of that Section or
Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The
information contained herein and in the accompanying exhibit shall not be
incorporated by reference into any filing with the U.S. Securities and Exchange
Commission made by Molecular Devices, whether made before or after the date
hereof, regardless of any general incorporation language in such filing.
Item 9.01. Financial Statements and Exhibits
(c) Exhibit
99.1 Press release dated October 28, 2004, entitled "Molecular
Devices Reports Record Revenues and Earnings for Third Quarter
of 2004", issued by Molecular Devices.
- --------------------------------------------------------------------------------
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
MOLECULAR DEVICES CORPORATION
Dated: October 28, 2004 By: /s/ Timothy A. Harkness
-------------------------------
Timothy A. Harkness
Senior Vice President and Chief
Financial Officer
- --------------------------------------------------------------------------------
Exhibit
99.1 Press release dated October 28, 2004, entitled "Molecular Devices Reports
Record Revenues and Earnings for Third Quarter of 2004", issued by
Molecular Devices.